Page last updated: 2024-11-06

prednisolone and Fibrocartilaginous Dysplasia of Bone

prednisolone has been researched along with Fibrocartilaginous Dysplasia of Bone in 1 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohrs, U1
Hauswaldt, C1
Hunstein, W1

Other Studies

1 other study available for prednisolone and Fibrocartilaginous Dysplasia of Bone

ArticleYear
[The modification of experimental bone marrow fibrosis after repeated administration of foreign proteins by antiphlogistics and prednisolone acetate].
    Blut, 1969, Volume: 19, Issue:7

    Topics: Anaphylaxis; Animals; Anti-Inflammatory Agents; Blood Cell Count; Blood Platelets; Body Weight; Bone

1969